Update on bacterial infections in immunosuppressed patients

Schimpff, 1972, Origin of infection in acute nonlymphocytic leukaemia. Significance of hospital acquisition of potential pathogens, Ann Intern Med, 77, 707, 10.7326/0003-4819-77-5-707 Freifeld, 2004, Low-risk patients with fever and neutropenia during chemotherapy: Current clinical practice patterns, Proc Am Soc Clin Oncol, 23, 747 Cruciani, 1996, Prophylaxis with fluorquinolones for bacterial infections in neutropenic patients: a meta-analysis, Clin Infect Dis, 23, 795, 10.1093/clinids/23.4.795 Engels, 1998, Efficacy of quinolone prophylaxis in neutropenic cancer patients: a meta-analysis, J Clin Oncol, 16, 1179, 10.1200/JCO.1998.16.3.1179 Hughes, 2002, 2002 Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer Clin Infect Dis, 34, 730 Ortega, 2005, Bacterial and fungal bloodstream isolates from 796 hematopoietic stem cell transplant recipients between 1991 and 2000, Ann Hematol, 84, 40, 10.1007/s00277-004-0909-0 Cordonnier, 2003, Epidemiology and risk factors for Gram-positive infections in neutropenia: toward a more targeted antibiotic strategy, Clin Infect Dis, 36, 149, 10.1086/345435 Yves, 1997, Virulent infections caused by alpha-haemolytic streptococci in cancer patients and their management, Curr Op Infect Dis, 10, 422, 10.1097/00001432-199712000-00002 Doern, 1996, Emergence of high rates of antimicrobial resistance among viridans group Streptococci in the United States, Antimicrob Agents Chemother, 40, 891, 10.1128/AAC.40.4.891 Karp, 1986, Empiric use vancomycin during prolonged treatment-induced granulocytopenia, Am J Med, 81, 237, 10.1016/0002-9343(86)90257-3 Shenep, 1988, Vancomycin, ticarcillin and amikacin compared with ticarcillin-clavulanate and amikacin in the empirical treatment of febrile, neutropenic children with cancer, N Engl J Med, 319, 1053, 10.1056/NEJM198810203191604 Micozzi, 1999, Piperacillin / tazobactam / amikacin versus piperacillin / amikacin / teicoplanin in the empirical treatment of neutropenic patients, Eur J Clin Microbiol Infect Dis, 12, 1, 10.1007/BF01997049 Rubin, 1988, Gram-positive infections and use of vancomycin in 550 episodes of fever and neutropenia, Ann Intern Med, 108, 30, 10.7326/0003-4819-108-1-30 1991, Vancomycin added to empirical combination antibiotic therapy for fever in granulocytopenic cancer patients, J infect Dis, 163, 951, 10.1093/infdis/163.5.951 Ramphal, 1992, Vancomycin is not an essential component of the initial empiric treatment regimen for febrile neutropenic patients receiving ceftazidime: a randomized prospective study, Antimicrob Agents Chemother, 36, 1062, 10.1128/AAC.36.5.1062 Talcott, 1988, The medical course of cancer patients with fever and neutropenia. Clinical identification of a low-risk subgroup at presentation, Arch Inten Med, 148, 2561, 10.1001/archinte.148.12.2561 Freifeld, 1999, A Double-Blind Comparison of Empirical Oral and Intravenous Antibiotic Therapy for Low-Risk Febrile Patients with Neutropenia during Cancer Chemotherapy, N Engl J Med, 341, 303, 10.1056/NEJM199907293410501 Kern, 1999, N Engl J Med, 341, 312, 10.1056/NEJM199907293410502 Talcott, 1992, Risk assessment in cancer patients with fever and neutropenia: a prospective, two-center validation of a prediction rule, J Clin Oncol, 10, 316, 10.1200/JCO.1992.10.2.316 Talcott, 1994, Home antibiotic therapy for low-risk cancer patients with fever and neutropenia: a pilot study of 30 patients based on a validated prediction rule, J Clin Oncol, 12, 107, 10.1200/JCO.1994.12.1.107 Klastersky, 2000, The Multinational Association for Supportive Care in Cancer risk index: A multinational scoring system for identifying low-risk febrile neutropenic cancer patients, J Clin Oncol, 18, 3038, 10.1200/JCO.2000.18.16.3038 Uys, 2004, Febrile neutropenia: a prospective study to validate the Multinational Association of Supportive Care of Cancer (MASCC) risk-index score, Support Care Cancer, 8, 555 Elting, 1997, Outcomes of bacteremia in patients with cancer and neutropenia: observations from two decades of epidemiological and clinical trials, Clin Infect Dis, 25, 247, 10.1086/514550 Hughes, 2002, 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer, Clin Infect Dis, 34, 730, 10.1086/339215